Di Nuzzo Private Wealth, Inc. Biomarin Pharmaceutical Inc Transaction History
Di Nuzzo Private Wealth, Inc.
- $658 Million
- Q2 2025
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 12 shares of BMRN stock, worth $713. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12
Previous 24
50.0%
Holding current value
$713
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding BMRN
# of Institutions
666Shares Held
186MCall Options Held
1.25MPut Options Held
992K-
Black Rock Inc. New York, NY22.7MShares$1.35 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.13 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA17.8MShares$1.06 Billion1.06% of portfolio
-
Dodge & Cox San Francisco, CA15MShares$889 Million0.65% of portfolio
-
Viking Global Investors LP10.8MShares$642 Million2.55% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...